Timothy Kocses

Executive Director, US Commercial Controller at Bristol Myers Squibb

Advisor

Tim is the Executive Director, US Commercial Finance Controller at BMS. In this role, he is responsible for overseeing all technical accounting, revenue recognition, gross to net reporting, process simplification for the US Commercial business, IRA implementation, working capital improvement opportunities and commercial aspects of business acquisitions. Additionally, he partners with the US Commercialization FP&A Access and Pricing teams to ensure alignment on GTN channels for actuals, analytics and forecasts across the US Oncology, Hematology, Immunology, Cardiovascular and Neuroscience therapeutic areas. This includes GTN reporting for products in the various stages of a commercial products lifecycle.

Tim joined BMS in mid-2013 and through late 2022, was the global Technical Accounting & Policy lead within the organization for over nine years. During this time, he lead the global Technical Accounting Network (TAN), oversaw the simplification of Finance Standard Operating Procedures (SOP's), supported the organization through several Accounting Standards Updates, championed the Revenue Center of Excellence (COE), provided business development accounting support and assisted the business through several organizational changes, including site rationalizations and restructuring. Additionally, he led the BMS Accounting Development Program (ADP).

Prior to joining BMS, Tim worked for KPMG LLP (“KPMG”) in the New Jersey audit practice from 2002 to 2013, serving clients primarily in the life-sciences sector.